SUBSTITUTED HETEROCYCLIC CSNK1 INHIBITORS

The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FERRARA, Steven, James, MCKINNEY, David, MORTIER, Jérémie, LEMOS, Clara, SHEKHAR, Mrinal, CHRISTIAN, Sven, BÖMER, Ulf, LECHNER, Christian, CORSELLO, Steven, KAULFUSS, Stefan, RUPAIMOOLE, Rajesha, WAGNER, Florence, F, SCHULZE, Volker, HANDING, Katarzyna, MENGEL, Anne, LIENAU, Philip, BRZEZINKA, Krzysztof, ORSI, Douglas, HILLIG, Roman, BERGER, Markus
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and associated methods of treating cancer.